Trinity Biotech amends Perceptive Advisors financing, adds USD 7 million investment
TRIB•Funding to support growth initiatives
The funding aims to support strategic growth initiatives, including the CGM+ platform, Trinovium, and a broader business transformation.
Additional financing from Perceptive Advisors
Trinity Biotech secured an additional USD 7 million investment from Perceptive Advisors under an amendment to existing financing arrangements.
The total comprises about USD 2.5 million of new debt funding, with about USD 4.5 million of capitalised interest.
